Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Entyvio“
Suchtreffer
Begriffe & Kennungen
Entyvio · 4.8 · In clinical studies with intravenous and subcutaneous vedolizumab, a slightly higher incidence of serious infe
Eintrag öffnenEntyvio · 4.8 · In clinical studies with intravenous vedolizumab (ulcerative colitis and Crohn’s disease), a slightly higher i
Eintrag öffnenEntyvio · 4.8 · In clinical studies with intravenous vedolizumab (ulcerative colitis and Crohn’s disease), the rate of infecti
Eintrag öffnenEntyvio · 4.8 · In clinical studies with subcutaneous vedolizumab, the rate of infections was 0.26 per patient year in vedoliz
Eintrag öffnenEntyvio · 4.8 · In clinical studies with subcutaneous vedolizumab, the rate of serious infections was 0.02 per patient year in
Eintrag öffnenEntyvio · 4.8 · In controlled and open-label studies (ulcerative colitis and Crohn’s disease) in adults with intravenous vedol
Eintrag öffnenEntyvio · 4.8 · In controlled and open-label studies in adults with intravenous vedolizumab, serious infections have been repo
Eintrag öffnenEntyvio · 4.8 · Infections
Eintrag öffnenEntyvio · 4.8 · Infections
Eintrag öffnenEntyvio · 4.8 · Infusion related reactions (with symptoms such as dyspnoea, bronchospasm, urticaria, flushing, rash, and incre
Eintrag öffnenEntyvio · 4.8 · Infusion-related reactions
Eintrag öffnenEntyvio · 4.8 · Injection site reactions
Eintrag öffnenEntyvio · 4.8 · Injection site reactions (including pain, oedema, erythema or pruritus) were reported in 5.1% of patients rece
Eintrag öffnenEntyvio · 4.8 · No clinically relevant differences in the overall safety profile and adverse reactions were observed in patien
Eintrag öffnenEntyvio · 4.8 · One serious adverse reaction of IRR was reported in a Crohn’s disease patient during the second infusion (symp
Eintrag öffnenEntyvio · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenEntyvio · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenEntyvio · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEntyvio · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenEntyvio · 4.8 · Summary of the safety profile
Eintrag öffnen